Ethics, profit and patients: when pharmaceutical companies sponsor medical meetings.
A series of dynamic changes underway in Washington could transform the manner in which physicians learn of new pharmaceutical therapies. The potential impact of these changes is likely to significantly affect the manner in which physicians learn about and prescribe medications for years to come; the ultimate effect on patient care has yet to be measured, however.
University of Nevada, Las Vegas.
L
L
Barton
D001291:Attitude of Health Personnel; D003132:Commerce / Q000592:standards*; D003226:Congresses as Topic / Q000592:standards; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000592:standards*; D004346:Drug Information Services; D004502:Education, Medical, Continuing / Q000592:standards*; D004995:Ethics, Professional; D017408:Guidelines as Topic; D007400:Interprofessional Relations; D010820:Physicians / Q000523:psychology / Q000706:statistics & numerical data; D011795:Surveys and Questionnaires; D014481:United States; D014486:United States Food and Drug Administration